Medtronic PLC
NYSE:MDT
Medtronic PLC
NYSE:MDT
Price:
80.92 USD
0.04%
Market Closed
Updated:
May 3, 2024
Medtronic PLC
Revenue
|
Medtronic PLC
Revenue Peer Comparison
Comparables:
TRIB
STE
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Medtronic PLC
NYSE:MDT
|
Revenue
$32.3B
|
CAGR 3-Years
5%
|
CAGR 5-Years
1%
|
CAGR 10-Years
7%
|
|
|
Trinity Biotech PLC
NASDAQ:TRIB
|
Revenue
$56.8m
|
CAGR 3-Years
-18%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
-5%
|
|
|
STERIS plc
NYSE:STE
|
Revenue
$5.4B
|
CAGR 3-Years
21%
|
CAGR 5-Years
15%
|
CAGR 10-Years
13%
|
Medtronic PLC
Revenue Breakdown
Breakdown by Geography
Medtronic PLC
Medtronic PLC
|
Total Revenue:
31.2B
USD
|
|
Total Other Countries, Excluding Ireland:
31.1B
USD
|
|
United States Pension Benefits:
16.4B
USD
|
|
Non-United States Developed Markets:
9.4B
USD
|
|
Emerging Markets:
5.4B
USD
|
|
Ireland:
98m
USD
|
Breakdown by Segments
Medtronic PLC
Medtronic PLC
|
Total Revenue:
31.2B
USD
|
|
Cardiovascular:
11.6B
USD
|
|
Neuroscience:
9B
USD
|
|
Medical Surgical:
8.4B
USD
|
|
Diabetes:
2.3B
USD
|
See Also
What is Medtronic PLC's Revenue?
Revenue
32.3B
USD
32.3B
USD
Based on the financial report for Jan 26, 2024, Medtronic PLC's Revenue amounts to 32.3B USD.
What is Medtronic PLC's Revenue growth rate?
Revenue CAGR 10Y
7%
7%
Over the last year, the Revenue growth was 5%. The average annual Revenue growth rates for Medtronic PLC have been 5% over the past three years , 1% over the past five years , and 7% over the past ten years .
You don't have any saved screeners yet
